Neovascularization, Pathologic

"Neovascularization, Pathologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.

Descriptor ID	D009389
MeSH Number(s)	C23.550.589.500
Concept/Terms	Neovascularization, Pathologic Neovascularization, Pathologic Pathologic Neovascularization Neovascularization, Pathological Pathological Neovascularization Pathologic Angiogenesis Angiogenesis, Pathologic Angiogenesis, Pathological Pathological Angiogenesis

Below are MeSH descriptors whose meaning is more general than "Neovascularization, Pathologic".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Metaplasia [C23.550.589]
Neovascularization, Pathologic [C23.550.589.500]

Below are MeSH descriptors whose meaning is related to "Neovascularization, Pathologic".

Below are MeSH descriptors whose meaning is more specific than "Neovascularization, Pathologic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neovascularization, Pathologic" by people in this website by year, and whether "Neovascularization, Pathologic" was a major or minor topic of these publications.

Bar chart showing 88 publications over 21 distinct years, with a maximum of 12 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2001	0	1	1
2002	2	1	3
2003	2	2	4
2004	0	3	3
2005	1	1	2
2006	4	3	7
2007	2	2	4
2008	2	3	5
2009	1	4	5
2010	2	2	4
2011	6	6	12
2012	3	0	3
2013	3	3	6
2014	1	4	5
2015	2	5	7
2016	3	3	6
2017	2	3	5
2018	2	0	2
2019	1	0	1
2020	1	1	2

Below are the most recent publications written about "Neovascularization, Pathologic" by people in Profiles.

Sun M, Wadehra M, Casero D, Lin MC, Aguirre B, Parikh S, Matynia A, Gordon L, Chu A. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2020 02 07; 61(2):3.

View in: PubMed
Patel KS, Kejriwal S, Sun MM, Thammachantha S, Duong C, Chan A, Cherian N, Romiyo P, Gordon LK, Yong W, Wadehra M, Yang I. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. J Neurooncol. 2020 Mar; 147(1):15-24.

View in: PubMed
Kelleher J, Dickinson A, Cain S, Hu Y, Bates N, Harvey A, Ren J, Zhang W, Moreton FC, Muir KW, Ward C, Touyz RM, Sharma P, Xu Q, Kimber SJ, Wang T. Patient-Specific iPSC Model of a Genetic Vascular Dementia Syndrome Reveals Failure of Mural Cells to Stabilize Capillary Structures. Stem Cell Reports. 2019 11 12; 13(5):817-831.

View in: PubMed
Wojnarowicz PM, Lima E Silva R, Ohnaka M, Lee SB, Chin Y, Kulukian A, Chang SH, Desai B, Garcia Escolano M, Shah R, Garcia-Cao M, Xu S, Kadam R, Goldgur Y, Miller MA, Ouerfelli O, Yang G, Arakawa T, Albanese SK, Garland WA, Stoller G, Chaudhary J, Norton L, Soni RK, Philip J, Hendrickson RC, Iavarone A, Dannenberg AJ, Chodera JD, Pavletich N, Lasorella A, Campochiaro PA, Benezra R. A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization. Cell Rep. 2019 10 01; 29(1):62-75.e7.

View in: PubMed
Bermea KC, Rodríguez-García A, Tsin A, Barrera-Saldaña HA. Somatolactogens and diabetic retinopathy. Growth Horm IGF Res. 2018 Aug; 41:42-47.

View in: PubMed
Zhang Z, Serrano-Negrón JE, Martínez JA, Baksi K, Banerjee DK. Dynamic Function of DPMS Is Essential for Angiogenesis and Cancer Progression. Adv Exp Med Biol. 2018; 1112:223-244.

View in: PubMed
Marciel MP, Hoffmann PR. Selenoproteins and Metastasis. Adv Cancer Res. 2017; 136:85-108.

View in: PubMed
Qin Y, Takahashi M, Sheets K, Soto H, Tsui J, Pelargos P, Antonios JP, Kasahara N, Yang I, Prins RM, Braun J, Gordon LK, Wadehra M. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme. J Neurooncol. 2017 Aug; 134(1):29-40.

View in: PubMed
Williams CJ, Chu A, Jefferson WN, Casero D, Sudhakar D, Khurana N, Hogue CP, Aryasomayajula C, Patel P, Sullivan P, Padilla-Banks E, Mohandessi S, Janzen C, Wadehra M. Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency. J Pathol. 2017 06; 242(2):246-259.

View in: PubMed
Humphries-Bickley T, Castillo-Pichardo L, Hernandez-O'Farrill E, Borrero-Garcia LD, Forestier-Roman I, Gerena Y, Blanco M, Rivera-Robles MJ, Rodriguez-Medina JR, Cubano LA, Vlaar CP, Dharmawardhane S. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer. . 2017 05; 16(5):805-818.

View in: PubMed

People

Explore

Similar Concepts

Top Journals